1. Home
  2. RYTM vs TSEM Comparison

RYTM vs TSEM Comparison

Compare RYTM & TSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • TSEM
  • Stock Information
  • Founded
  • RYTM 2008
  • TSEM 1993
  • Country
  • RYTM United States
  • TSEM Israel
  • Employees
  • RYTM N/A
  • TSEM N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • TSEM Semiconductors
  • Sector
  • RYTM Health Care
  • TSEM Technology
  • Exchange
  • RYTM Nasdaq
  • TSEM Nasdaq
  • Market Cap
  • RYTM 4.3B
  • TSEM 4.6B
  • IPO Year
  • RYTM 2017
  • TSEM 1994
  • Fundamental
  • Price
  • RYTM $65.25
  • TSEM $42.42
  • Analyst Decision
  • RYTM Strong Buy
  • TSEM Strong Buy
  • Analyst Count
  • RYTM 12
  • TSEM 3
  • Target Price
  • RYTM $77.50
  • TSEM $60.00
  • AVG Volume (30 Days)
  • RYTM 585.3K
  • TSEM 600.1K
  • Earning Date
  • RYTM 08-05-2025
  • TSEM 07-23-2025
  • Dividend Yield
  • RYTM N/A
  • TSEM N/A
  • EPS Growth
  • RYTM N/A
  • TSEM N/A
  • EPS
  • RYTM N/A
  • TSEM 1.80
  • Revenue
  • RYTM $136,863,000.00
  • TSEM $1,467,054,000.00
  • Revenue This Year
  • RYTM $37.56
  • TSEM $10.30
  • Revenue Next Year
  • RYTM $74.99
  • TSEM $11.17
  • P/E Ratio
  • RYTM N/A
  • TSEM $24.10
  • Revenue Growth
  • RYTM 48.88
  • TSEM 5.22
  • 52 Week Low
  • RYTM $40.46
  • TSEM $28.64
  • 52 Week High
  • RYTM $69.89
  • TSEM $55.31
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 53.08
  • TSEM 56.09
  • Support Level
  • RYTM $60.80
  • TSEM $38.90
  • Resistance Level
  • RYTM $64.00
  • TSEM $44.29
  • Average True Range (ATR)
  • RYTM 1.96
  • TSEM 1.34
  • MACD
  • RYTM -0.13
  • TSEM 0.22
  • Stochastic Oscillator
  • RYTM 44.48
  • TSEM 72.54

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.

Share on Social Networks: